KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to 0.82.

  • Acadia Pharmaceuticals' Asset Utilization Ratio fell 16.64% to 0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82, marking a year-over-year decrease of 16.64%. This contributed to the annual value of 0.99 for FY2024, which is 8.99% down from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.82 for Q3 2025, which was down 5.21% from 0.86 recorded in Q2 2025.
  • Acadia Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 1.05 for Q4 2023, and its period low was 0.60 during Q1 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.92, with a median of 0.88 in 2024.
  • In the last 5 years, Acadia Pharmaceuticals' Asset Utilization Ratio skyrocketed by 32.27% in 2022 and then fell by 16.64% in 2025.
  • Acadia Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.68 in 2021, then rose by 27.25% to 0.87 in 2022, then climbed by 21.01% to 1.05 in 2023, then declined by 15.85% to 0.88 in 2024, then dropped by 16.64% to 0.82 in 2025.
  • Its Asset Utilization Ratio stands at 0.82 for Q3 2025, versus 0.86 for Q2 2025 and 0.86 for Q1 2025.